The University of Nebraska Medical Center is involved in testing a drug the Food and Drug Administration has fast-tracked towards approval because of its dramatic results in patients with mantle cell lymphoma and other cancers.
http://www.medilexicon.com/medicalnews.php?newsid=264120
http://www.medilexicon.com/medicalnews.php?newsid=264120
No comments:
Post a Comment